As FDA considers a new paradigm that would expand the definition of nonprescription drugs, healthcare experts say the proposed paradigm could have its benefits and challenges for the healthcare industry.
As FDA considers a new paradigm that would expand the definition of nonprescription drugs, healthcare experts say the proposed paradigm could have its benefits and challenges for the healthcare industry.
The paradigm would allow some medications that would usually require a prescription to be distributed over-the-counter (OTC) if certain special conditions were met. While the details of the proposed change are still unclear, these special conditions could require customers to speak with a pharmacist or submit to a diagnostic test before the product was available for purchase. They might also require that a person visits a physician to get an initial prescription but then would be able to get refills without an additional doctor's visit.
The type of medications that could fall into this new paradigm has not been determined; however, previous discussion has included emergency medications, anecdotes, or medications that aid in chronic disease management.
Healthcare experts said the advantage of such a paradigm could be a reduction in overall healthcare costs, improved patient access to healthcare, and improved efficiencies.
Pharmacists may be uniquely qualified to play a greater role in medication management because they are easily accessible, often have already established relationships within the community, and are skilled in drug therapy, Reilly said.
However, she was quick to point out that the proposal was not meant to minimize the role of the primary care physician and called it a "collaboration."
The new paradigm could not only improve patient quality of life but it could also help reduce hospital costs and admissions if patients are able to access medication, such as an EpiPen, in emergency situations or restart medication for chronic disease management, according to Marissa Schlaifer, RPh, MS, director of pharmacy affairs for the Academy of Managed Care Pharmacy.
"The benefit for the health plan and for the patient is that in general patient access to medications they need is going to improve their health," she said.
But experts also said there are concerns with the proposed paradigm.
A primary concern for pharmacists is the potential impact it could have on workload. "Most pharmacists, even if they wanted to do this with 20 patients a day, couldn't find the time to do it," Gallagher said. "There's going to have to be a reimbursement model that would build bandwidth for pharmacists to hire additional staff to help them do this."
Standardized processes also would need to be in place so that every anti-hypertensive, for example, would not have separate, unique algorithms, Gallagher added.
Dr Bender favors a process similar to a behind-the-counter use, where patients need to consult with a pharmacist before they have access to the medication.
Coalition promotes important acetaminophen dosing reminders
November 18th 2014It may come as a surprise that each year Americans catch approximately 1 billion colds, and the Centers for Disease Control and Prevention estimates that as many as 20% get the flu. This cold and flu season, 7 in 10 patients will reach for an over-the-counter (OTC) medicine to treat their coughs, stuffy noses, and sniffles. It’s an important time of the year to remind patients to double check their medicine labels so they don’t double up on medicines containing acetaminophen.
Support consumer access to specialty medications through value-based insurance design
June 30th 2014The driving force behind consumer cost-sharing provisions for specialty medications is the acquisition cost and not clinical value. This appears to be true for almost all public and private health plans, says a new report from researchers at the University of Michigan Center for Value-Based Insurance Design (V-BID Center) and the National Pharmaceutical Council (NPC).
Management of antipsychotic medication polypharmacy
June 13th 2013Within our healthcare-driven society, the increase in the identification and diagnosis of mental illnesses has led to a proportional increase in the prescribing of psychotropic medications. The prevalence of mental illnesses and subsequent treatment approaches may employ monotherapy as first-line treatment, but in many cases the use of combination of therapy can occur, leading to polypharmacy.1 Polypharmacy can be defined in several ways but it generally recognized as the use of multiple medications by one patient and the most common definition is the concurrent use of five more medications. The presence of polyharmacy has the potential to contribute to non-compliance, drug-drug interactions, medication errors, adverse events, or poor quality of life.
Medical innovation improves outcomes
June 12th 2013I have been diagnosed with stage 4 cancer of the pancreas, a disease that’s long been considered not just incurable, but almost impossible to treat-a recalcitrant disease that some practitioners feel has given oncology a bad name. I was told my life would be measured in weeks.